Evaxion Biotech A/S announced it will report first quarter 2026 financial results and provide a business update on May 7, 2026, before the Nasdaq CM opening.
Key takeaways
Evaxion will report Q1 2026 financial results on May 7, 2026, before market open.
Management will host a conference call and webcast at 14:30 CET / 08:30 EST on May 7.
The company is a clinical-stage TechBio company utilizing its AI-Immunology™ platform for vaccine development.